Description
Varenicline Tablets
Healthy Inc is a specialized global supplier and exporter of advanced respiratory, psychiatric, and public health therapeutics. We provide ultra-high-purity, structurally validated Varenicline Tablets (0.5 mg / 1 mg), manufactured in WHO–GMP certified, strictly nitrosamine-monitored oral solid dosage facilities. This “Nicotinic Receptor Partial Agonist” is a massive-volume, priority export to respiratory clinics, national smoking cessation programs, primary care networks, and government health ministries in LATAM, the Middle East, Africa, and Southeast Asia, serving as the globally trusted, definitive pharmacological intervention for overcoming tobacco dependence.
Product Overview
This formulation contains Varenicline (as Varenicline Tartrate), a highly targeted neuro-modulator that fundamentally alters the brain’s relationship with nicotine via a brilliant dual-action mechanism.
The “Receptor Blockade & Craving Suppression” Specialist:
- Mechanism 1 (The Agonist Effect – Craving Relief): Nicotine addiction is driven by the release of dopamine when nicotine binds to the α4β2 nicotinic acetylcholine receptors in the brain. Varenicline acts as a “partial agonist.” It binds to these exact same receptors and stimulates a low, steady release of dopamine—enough to drastically reduce the agonizing physical cravings and withdrawal symptoms associated with quitting smoking, but not enough to create a “high.”
- Mechanism 2 (The Antagonist Effect – Reward Blockade): Because Varenicline has a much higher affinity for these receptors than nicotine does, it physically occupies the receptor sites. If a patient gives in to temptation and smokes a cigarette, the nicotine cannot bind to the receptors. The neurological “reward” or “buzz” of smoking is completely blocked, helping to extinguish the behavioral habit.
- The Public Health Champion: Because it tackles both the physiological withdrawal and the psychological reward simultaneously, Varenicline vastly outperforms nicotine replacement therapies (patches/gums) and older drugs like Bupropion in long-term clinical quit rates.
Product Composition & Strength
We supply this product as a Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-Alu blister strips. We specifically offer the globally mandated “Titration Starter Packs” to ensure patient compliance during the critical first two weeks of therapy.
| Active Ingredient | Strength | Primary Clinical Use |
|---|---|---|
| Varenicline Tartrate INN/USP | 0.5 mg | Mandatory dose-titration initiation (Days 1 through 7 of the quit attempt). |
| Varenicline Tartrate INN/USP | 1 mg | Standard Adult Maintenance Dose (Day 8 through Week 12 or 24). |
| Excipients | Microcrystalline Cellulose / Anhydrous Dibasic Calcium Phosphate / Croscarmellose Sodium | Diluent / Superdisintegrant (Ensures rapid, uniform gastric dispersion) |
*Pack Sizes: 11-Tablet Titration Starter Blisters (0.5mg & 1mg combo) / standard 10×10 Maintenance Blisters (1mg).
Technical & Logistics Specifications
Critical data for Pharmaceutical Importers, Public Health NGOs, and Respiratory Networks.
| HS Code | 3004.90.99 (Medicaments containing other active substances – CNS/Respiratory) |
| CAS Number | 375815-87-5 (Varenicline Tartrate) |
| Dosage Form | Film-Coated Tablet |
| Packaging | Custom-Printed Alu-Alu Blister Packs. Starter packs require highly complex, day-by-day directional printing on the foil backing to ensure the patient follows the strict titration schedule. |
| Storage | Store strictly below 30°C in a dry place. Protect from Light and Moisture. |
| Certificates | WHO-GMP, COPP, Free Sale Certificate |
Manufacturing Authority
Marketed and Distributed by Healthy Inc from WHO-GMP & ISO 9001:2015 certified units.
- Nitrosamine Impurity Eradication (CRITICAL COMPLIANCE): The global supply of Varenicline was severely disrupted due to the presence of N-nitroso-varenicline, a probable human carcinogen. Healthy Inc utilizes strictly vetted API sources and advanced LC-MS/MS (Liquid Chromatography-Mass Spectrometry) batch testing to guarantee our tablets are completely free of nitrosamine impurities, operating well within the strictest FDA and EMA acceptable intake limits.
- Complex Blister Engineering: Formulating the “Starter Pack” requires highly synchronized blister-packing machinery capable of securely alternating 0.5mg and 1mg tablets within the same blister card, matched with precise patient-adherence foil printing.
Therapeutic Indications (Human Use)
Indicated for the comprehensive management of severe behavioral and chemical dependency:
- Smoking Cessation: Indicated as an aid to smoking cessation treatment in adults, universally deployed alongside behavioral counseling and support.
Dosage & Administration
Recommended Dosage (Strictly as per Physician/Smoking Cessation Clinic):
- The “Quit Date” Protocol: The patient must set a target date to stop smoking. Varenicline dosing begins 1 to 2 weeks BEFORE this quit date to allow the drug to build up in the brain and block the receptors.
- Strict Titration Schedule:
- Days 1–3: 0.5 mg once daily.
- Days 4–7: 0.5 mg twice daily.
- Day 8 to End of Treatment (12-24 weeks): 1 mg twice daily.
- Administration (GASTRIC TOLERABILITY RULE): Varenicline frequently causes severe nausea. It MUST be taken after eating a full meal and swallowed with a full glass of water to drastically reduce gastric distress.
Safety Warnings (CRITICAL):
- Neuropsychiatric Symptoms: Varenicline can cause profound mood changes, including severe depression, agitation, aggression, and suicidal ideation/behavior. Patients and caregivers must be rigorously counseled to immediately stop the medication and contact a doctor if uncharacteristic behavioral shifts occur.
- Vivid Dreams & Insomnia: The drug frequently causes extremely vivid, sometimes disturbing, abnormal dreams. Taking the second daily dose earlier in the evening (rather than right before bed) can help mitigate insomnia.
- Cardiovascular Events: Clinical data suggests a small, increased risk of cardiovascular events (angina, non-fatal myocardial infarction) in patients who already have pre-existing cardiovascular disease. Physicians must weigh this risk against the massive cardiovascular benefits of successfully quitting smoking.
Global Export & Contract Manufacturing Services
Healthy Inc stands as a premier Pharmaceutical Exporter in India, dedicated to serving the needs of international Pharma Traders, Wholesalers, and Bulk Drug Distributors. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) services for Advanced CNS and Respiratory Formulations, allowing brands to launch high-quality generic medicines under their own label. Whether you are looking for a reliable Government Tender Supplier for national smoking cessation programs in Africa or a B2B Pharma Marketplace partner for Latin America, our logistics network ensures timely delivery. We actively support Pharmaceutical Drop Shipping models and bulk indenting, ensuring that every Generic Medicine Wholesaler receives WHO-GMP certified products at competitive rates.








Reviews
There are no reviews yet.